FDA Inspection
Shire Human Genetic Therapies, Inc.Shire Human Genetic Therapies, Inc. – FDA Inspection, Jan 15, 2020
Record Details
This FDA Inspection record concerns Shire Human Genetic Therapies, Inc., with an inspection on January 15, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 15, 2020
- Product Type
- Drugs
View Company Profile
ID · 1ae8f893-5541-4ec2-bd26-a3c8369df807
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1116968
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Shire Human Genetic Therapies, Inc.
20| Date | Classification | Office | Project area |
|---|---|---|---|
| December 18, 2025 | Not classified | New England District Office | |
| April 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2018 | Not classified | New England District Office | |
| July 25, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shire Human Genetic Therapies, Inc.
- FDA Inspection 1297340 - 2025-12-18
- FDA Inspection 1167818 - 2022-04-22
- FDA Inspection 1106210 - 2018-11-09
- FDA Inspection 1061705 - 2018-07-25
- FDA Inspection 1004081 - 2017-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.